positions available now

Tag Archives: National Medicines Policy

Pricing is important, but what about access and quality use of medicines?

The recent PBS Access and Sustainability package provides significant savings from pricing measures including removing the originator brand from price disclosure calculations, a one-off 5% reduction to F1 medicines listed for at least 5 years, flow on reductions for F2 … Continue reading

Posted in Life Sciences Industry, Market Access | Tagged , , | Comments Off on Pricing is important, but what about access and quality use of medicines?

Right Message, Right People, Right Time

The pharmaceutical industry needs to expand the ‘right drug, right dose, right time’ mantra. Continue reading

Posted in Life Sciences Industry | Tagged , | Comments Off on Right Message, Right People, Right Time
Copyright © 2014 Commercial Eyes